معرفی
Dr. Declan Whyte serves as an Affiliate within the School of Cancer Sciences at the University of Glasgow, affiliated with the CRUK Scotland Institute. His research focuses on molecular mechanisms in oncology, particularly kinase signaling pathways.
His primary research interests center on kinase biology and cancer signaling pathways, with emphasis on NUAK kinases' role in tumor development and therapeutic targeting. Current work explores metabolic regulation in proliferating cancer cells and potential drug discovery avenues.
Dr. Whyte's recent publication analyzes NUAK kinases' multifaceted functions in cellular processes relevant to oncology. His work demonstrates trends toward understanding underexplored kinases in cancer metabolism and identifying novel therapeutic targets within signaling networks.
While no specific awards are listed in available materials, his research contributes to the CRUK Scotland Institute's mission in advancing cancer science.
As an Affiliate researcher, Dr. Whyte collaborates within the CRUK Scotland Institute ecosystem, contributing to molecular oncology projects through biochemical and cellular analysis. His work supports broader institute goals in translating basic science into clinical applications.
